Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Central Pacific Financial
CPF
$1.02B
| $12.1M | ﹤0.01% |
463,652
-1,258
| -0.3% | -$34.5K |
|
|
ALTA
2327
DELISTED
Altabancorp
ALTA
| $12.1M | ﹤0.01% |
278,812
+14,114
| +5% | +$616K |
|
|
IGMS
2328
DELISTED
IGM Biosciences
IGMS
| $12.1M | ﹤0.01% |
145,009
+8,943
| +7% | +$663K |
|
2329
uniQure
QURE
$3.02B
| $12.1M | ﹤0.01% |
391,367
+25,718
| +7% | +$862K |
|
2330
Paysafe
PSFE
$398M
| $12M | ﹤0.01% |
+82,876
| New | +$12.4M |
|
|
CCXI
2331
DELISTED
ChemoCentryx, Inc.
CCXI
| $12M | ﹤0.01% |
898,738
+44,828
| +5% | +$1.1M |
|
2332
Digi International
DGII
$2.73B
| $12M | ﹤0.01% |
596,498
+69,193
| +13% | +$1.3M |
|
|
ASXC
2333
DELISTED
Asensus Surgical, Inc.
ASXC
| $12M | ﹤0.01% |
3,783,768
+2,755,703
| +268% | +$6.89M |
|
2334
Stoke Therapeutics
STOK
$1.87B
| $12M | ﹤0.01% |
356,246
+63,210
| +22% | +$2.23M |
|
2335
HUTCHMED
HCM
$2.02B
| $12M | ﹤0.01% |
307,478
+39,338
| +15% | +$1.14M |
|
2336
Scholar Rock
SRRK
$5.61B
| $12M | ﹤0.01% |
413,930
+13,735
| +3% | +$420K |
|
2337
Camden National
CAC
$1B
| $11.9M | ﹤0.01% |
249,967
-9,666
| -4% | -$459K |
|
2338
Anterix
ATEX
$1.94B
| $11.9M | ﹤0.01% |
198,930
+6,340
| +3% | +$318K |
|
|
SP
2339
DELISTED
SP Plus Corporation
SP
| $11.9M | ﹤0.01% |
389,684
+1,654
| +0.4% | +$54.2K |
|
2340
Precigen
PGEN
$2.27B
| $11.9M | ﹤0.01% |
1,825,435
+334,776
| +22% | +$2.34M |
|
2341
PMV Pharmaceuticals
PMVP
$59.2M
| $11.9M | ﹤0.01% |
348,181
+102,095
| +41% | +$3.41M |
|
|
CIO
2342
DELISTED
City Office REIT
CIO
| $11.9M | ﹤0.01% |
956,037
+11,980
| +1% | +$139K |
|
2343
IDT Corp
IDT
$1.64B
| $11.8M | ﹤0.01% |
320,008
+6,044
| +2% | +$172K |
|
|
ALX
2344
Alexander's
ALX
$1.33B
| $11.8M | ﹤0.01% |
43,991
+1,823
| +4% | +$505K |
|
|
SPTN
2345
DELISTED
SpartanNash
SPTN
| $11.8M | ﹤0.01% |
610,402
+14,652
| +2% | +$292K |
|
|
XXII
2346
22nd Century Group
XXII
$1.47M
| – | – |
0
| – | – |
|
|
ECOM
2347
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $11.8M | ﹤0.01% |
479,408
+20,482
| +4% | +$492K |
|
2348
World Acceptance Corp
WRLD
$892M
| $11.7M | ﹤0.01% |
73,238
+1,366
| +2% | +$200K |
|
2349
Outdoor Holding Co
POWW
$254M
| $11.7M | ﹤0.01% |
1,195,808
+718,971
| +151% | +$5.11M |
|
2350
Vaxcyte
PCVX
$7.82B
| $11.7M | ﹤0.01% |
518,974
+98,086
| +23% | +$2.01M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.